CD4+CD25−Nrp1+ T Cells Synergize with Rapamycin to Prevent Murine Cardiac Allorejection in Immunocompetent Recipients
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CD4+CD25−Nrp1+ T Cells Synergize with Rapamycin to Prevent Murine Cardiac Allorejection in Immunocompetent Recipients
Authors
Keywords
-
Journal
PLoS One
Volume 8, Issue 4, Pages e61151
Publisher
Public Library of Science (PLoS)
Online
2013-04-06
DOI
10.1371/journal.pone.0061151
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Neuropilin 1 is expressed on thymus-derived natural regulatory T cells, but not mucosa-generated induced Foxp3+T reg cells
- (2012) Jonathan M. Weiss et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivo
- (2012) Mahesh Yadav et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Differing Semaphorin 3A Concentrations Trigger Distinct Signaling Mechanisms in Growth Cone Collapse
- (2012) R. P. C. Manns et al. JOURNAL OF NEUROSCIENCE
- Molecular and functional heterogeneity of T regulatory cells
- (2011) Lequn Li et al. CLINICAL IMMUNOLOGY
- TGF-β in transplantation tolerance
- (2011) Frederico S Regateiro et al. CURRENT OPINION IN IMMUNOLOGY
- Neuropilin-1 attenuates autoreactivity in experimental autoimmune encephalomyelitis
- (2011) Benjamin D. Solomon et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Regulatory T cell therapy for the induction of clinical organ transplantation tolerance
- (2011) Huimin Fan et al. SEMINARS IN IMMUNOLOGY
- Tolerogenic dendritic cells and their role in transplantation
- (2011) Mohamed Ezzelarab et al. SEMINARS IN IMMUNOLOGY
- Regulatory T Cells in Transplantation
- (2011) K.J. Wood TRANSPLANTATION PROCEEDINGS
- Ex Vivo-Expanded Natural CD4+CD25+ Regulatory T Cells Synergize With Host T-Cell Depletion to Promote Long-Term Survival of Allografts
- (2010) G. Xia et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Rapamycin in combination with donor-specific CD4+CD25+Treg cells amplified in vitro might be realize the immune tolerance in clinical organ transplantation
- (2010) Chuntao Zhang et al. CELLULAR IMMUNOLOGY
- Adoptive transfer of DNT cells induces long-term cardiac allograft survival and augments recipient CD4+Foxp3+ Treg cell accumulation
- (2010) Zhu-Xu Zhang et al. TRANSPLANT IMMUNOLOGY
- Neuropilin‐1 is not a marker of human Foxp3+Treg
- (2009) Pierre Milpied et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Sequential evolution of IL-17 responses in the early period of allograft rejection
- (2009) Sang Il Min et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- Combined therapy of CD4+CD25+ regulatory T cells with low-dose sirolimus, but not calcineurin inhibitors, preserves suppressive function of regulatory T cells and prolongs allograft survival in mice
- (2009) Anlun Ma et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Mammalian Target of Rapamycin Inhibition and Alloantigen-Specific Regulatory T Cells Synergize To Promote Long-Term Graft Survival in Immunocompetent Recipients
- (2009) G. Raimondi et al. JOURNAL OF IMMUNOLOGY
- Neuropilin-1 Expression on Regulatory T Cells Enhances Their Interactions with Dendritic Cells during Antigen Recognition
- (2008) Milka Sarris et al. IMMUNITY
- Metabolic Stress Induces the Lysosomal Degradation of Neuropilin-1 but Not Neuropilin-2
- (2008) Donggoo Bae et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Neuropilin-1 is a receptor for transforming growth factor β-1, activates its latent form, and promotes regulatory T cell activity
- (2008) Yelena Glinka et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Neuropilin-1 expression identifies a subset of regulatory T cells in human lymph nodes that is modulated by preoperative chemoradiation therapy in cervical cancer
- (2007) Alessandra Battaglia et al. IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started